Book contents
- Individualized In-Vitro Fertilization
- Individualized In-Vitro Fertilization
- Copyright page
- Contents
- Contributors
- Chapter 1 Individualized Ovarian Stimulation for Normal and High Responders
- Chapter 2 Individualized Ovarian Stimulation in Patients with Advanced Maternal Age and Premature Ovarian Aging
- Chapter 3 Individualized Oocyte Maturation
- Chapter 4 Individualized Luteal Phase Support
- Chapter 5 Individualized Management of Male Infertility
- Chapter 6 Individualized Fertilization Technique in the IVF Laboratory
- Chapter 7 Individualized Genetic Testing
- Chapter 8 Individualized Embryo Selection
- Chapter 9 Preparation for Optimal Endometrial Receptivity in Cryo Cycles
- Chapter 10 Individualized Immunological Testing in Recurrent Implantation Failure
- Chapter 11 Individualized Embryo Transfer
- Index
- Plate Section (PDF Only)
- References
Chapter 10 - Individualized Immunological Testing in Recurrent Implantation Failure
Published online by Cambridge University Press: 12 February 2021
Book contents
- Individualized In-Vitro Fertilization
- Individualized In-Vitro Fertilization
- Copyright page
- Contents
- Contributors
- Chapter 1 Individualized Ovarian Stimulation for Normal and High Responders
- Chapter 2 Individualized Ovarian Stimulation in Patients with Advanced Maternal Age and Premature Ovarian Aging
- Chapter 3 Individualized Oocyte Maturation
- Chapter 4 Individualized Luteal Phase Support
- Chapter 5 Individualized Management of Male Infertility
- Chapter 6 Individualized Fertilization Technique in the IVF Laboratory
- Chapter 7 Individualized Genetic Testing
- Chapter 8 Individualized Embryo Selection
- Chapter 9 Preparation for Optimal Endometrial Receptivity in Cryo Cycles
- Chapter 10 Individualized Immunological Testing in Recurrent Implantation Failure
- Chapter 11 Individualized Embryo Transfer
- Index
- Plate Section (PDF Only)
- References
Summary
Human reproduction is an inefficient process. Still today is no clear definition for recurrent implantation failure (RIF). It is a condition arising from the failure of a successive number of in vitro fertilization cycles (IVF) in which theoretically the pregnancy should have already been achieved. Due to the disparity in the implantation and pregnancy rates among different assisted reproduction centers, a consensus definition has not been achieved. Technological and scientific advances in the field of ART have led to better reproductive outcomes. Despite all the efforts, around 30 percent of healthy euploid embryos still fail to implant today ().
- Type
- Chapter
- Information
- Individualized In-Vitro FertilizationDelivering Precision Fertility Treatment, pp. 121 - 129Publisher: Cambridge University PressPrint publication year: 2021
References
Franasiak, JM, Scott, RT. Contribution of immunology to implantation failure of euploid embryos. Fertil Steril 2017;107:1279–1283.CrossRefGoogle ScholarPubMed
Alecsandru, D, García-Velasco, JA. Immune testing and treatment: still an open debate. Hum Reprod 2015;30:1994.CrossRefGoogle ScholarPubMed
Sacks, G. Enough! Stop the arguments and get on with the science of naturalkiller cell testing. Hum Reprod 2015;30:1526–1531.Google Scholar
Tang, AW, Alfirevic, Z, Quenby, S. Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum Reprod 2011;26:1971–1980.Google Scholar
Moffett, A, Shreeve, N. Reply: First do no harm: continuing the uterine NK celldebate. Hum Reprod 2015;31:218–219.CrossRefGoogle Scholar
Moffett, A, Shreeve, N. First do no harm: uterine natural killer (NK) cells in assisted reproduction. Hum Reprod 2015;30:1519–1525.Google Scholar
Alecsandru, D, García-Velasco, JA. Immunology and human reproduction. Curr Opin Obstet Gynecol 2015;27:231–234.Google Scholar
Farag, SS, Caligiuri, MA. Human natural killer cell development and biology. Blood Rev 2006;20:123–137.CrossRefGoogle ScholarPubMed
Moffett, A, Chazara, O, Colucci, F. Maternal allo-recognition of the fetus. Fertil Steril 2017;107:1269–1272.CrossRefGoogle ScholarPubMed
Trundley, A, Moffett, A. Human uterine leukocytes and pregnancy. Tissue Antigens 2004;63:1–12.Google Scholar
Moffett, A, Colucci, F. Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction. Immunol Rev 2015;267:283–297.CrossRefGoogle ScholarPubMed
Koopman, LA, Kopcow, HD, Rybalov, B, et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003;198:1201–1212.CrossRefGoogle ScholarPubMed
Siewiera, J, El Costa, H, Tabiasco, J, et al. Human cytomegalovirus infection elicits new decidual natural killer cell effector functions. PLoS Pathog 2013;9:e1003257.Google Scholar
Hiby, SE, Regan, L, Lo, W, et al. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod 2008;23:972–976.CrossRefGoogle ScholarPubMed
Hiby, SE, Apps, R, Sharkey, AM, et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest 2010;120:4102–4110.CrossRefGoogle ScholarPubMed
Alecsandru, D, Garrido, N, Vicario, JL, et al. Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure. Hum Reprod 2014;29:2637–2643.Google Scholar
Alecsandru, D, García-Velasco, JA. Why natural killer cells are not enough: a further understanding of killer immunoglobulin-like receptor and human leukocyte antigen. Fertil Steril 2017;107:1273–1278.CrossRefGoogle Scholar
Moffett, A, Colucci, F. Uterine NK cells: active regulators at the maternal-fetalinterface. J Clin Invest 2014;124:1872–1879.CrossRefGoogle Scholar
Skjaerven, R, Vatten, LJ, Wilcox, AJ, et al. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ 2005;331:877.CrossRefGoogle Scholar
Marder, W, Littlejohn, EA, Somers, EC. Pregnancy and autoimmune connective tissue diseases. Best Pract Res Clin Rheumatol 2016;30(1):63–80.CrossRefGoogle ScholarPubMed
Lambert, M, Hocké, C, Jimenez, C, et al. Repeated in vitro fertilization failure: Abnormalities identified in the diagnostic assessment. Gynecol Obstet Fertil 2016;44(10):565–571.Google Scholar
Andreoli, L. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76(3):476–485.CrossRefGoogle ScholarPubMed
Khizroeva, J, Makatsariya, A, Bitsadze, V, et al. In vitro fertilization outcomes in women with antiphospholipid antibodies circulation. J Matern Fetal Neonatal Med 2018;33:1–11.Google Scholar
Ata, B, Urman, B. Thrombophilia and assisted reproduction technology-any detrimental impact or unnecessary overuse? J Assist Reprod Genet 2016;33:1305–1310.CrossRefGoogle ScholarPubMed
Alecsandru, D, López-Palacios, N, Mercedes, C, et al. Exploring undiagnosed celiac disease in women with recurrent reproductive failure: reproductive outcomes could improve with a gluten free diet. Am J Reprod Immunol 2019;10:e13209.Google Scholar
Alecsandru, D, Barrio, A, Andia, V, et al. Pancreatic autoimmunity: an unknown etiology on patients with assisted reproductive techniques (ART)-recurrent reproductive failure. PLoS One 2018;13(10):e0203446.Google Scholar
Parental human leukocyte antigen-C allotypes are predictive of live birth rate and risk of poor placentation in assisted reproductive treatment. Alecsandru, D, Barrio A, Garrido N, Aparicio P, Pellicer A, Moffett A, García-Velasco JA. Fertil Steril. 2020 Jul 30:S0015-0282(20)30443-XGoogle Scholar